Methylation of the RARB gene increases prostate cancer risk in black Americans

Journal of Urology

Volumn 190, Issue 1, 2013, Pages 317-324

  Tang, Deliang ^a   Kryvenko, Oleksandr N ^b   Mitrache, Nicoleta ^b   Do, Kieu C ^c   Jankowski, Michelle ^b   Chitale, Dhananjay A ^b   Trudeau, Sheri ^b   Rundle, Andrew ^a   Belinsky, Steven A ^c   Rybicki, Benjamin A ^b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b HENRY FORD HEALTH SYSTEM   (United States)

^c LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

Author keywords

African Americans; DNA methylation; prostate; prostatic neoplasms; risk

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BENIGN TUMOR; CANCER GRADING; CANCER PATIENT; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; DNA METHYLATION; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; RACE DIFFERENCE; TUMOR BIOPSY;

AFRICAN AMERICANS; AGE DISTRIBUTION; AGED; BIOPSY, NEEDLE; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; DNA METHYLATION; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; ODDS RATIO; PROGNOSIS; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; RECEPTORS, RETINOIC ACID; REFERENCE VALUES; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 84878827040     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2013.01.083     Document Type: Article

References (26)

1. M.O. Hoque DNA methylation changes in prostate cancer: current developments and future clinical implementation Expert Rev Mol Diagn 9 2009 243
2. S. Yegnasubramanian, J. Kowalski, M.L. Gonzalgo Hypermethylation of CpG islands in primary and metastatic human prostate cancer Cancer Res 64 2004 1975
3. W.G. Nelson, S. Yegnasubramanian, A.T. Agoston Abnormal DNA methylation, epigenetics, and prostate cancer Front Biosci 12 2007 4254
4. J.D. Brooks, M. Weinstein, X. Lin CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia Cancer Epidemiol Biomarkers Prev 7 1998 531
5. D.S. Millar, K.K. Ow, C.L. Paul Detailed methylation analysis of the glutathione S-transferase pi (GSTP1) gene in prostate cancer Oncogene 18 1999 1313
6. J.A. Hanson, J.W. Gillespie, A. Grover Gene promoter methylation in prostate tumor-associated stromal cells J Natl Cancer Inst 98 2006 255
7. D.A. Troyer, M.S. Lucia, A.P. de Bruine Prostate cancer detected by methylated gene markers in histopathologically cancer-negative tissues from men with subsequent positive biopsies Cancer Epidemiol Biomarkers Prev 18 2009 2717
8. I. Steiner, K. Jung, P. Schatz Gene promoter methylation and its potential relevance in early prostate cancer diagnosis Pathobiology 77 2010 260
9. J. Mehrotra, S. Varde, H. Wang Quantitative, spatial resolution of the epigenetic field effect in prostate cancer Prostate 68 2008 152
10. M. Truong, B. Yang, A. Livermore Using the epigenetic field defect to detect prostate cancer in biopsy negative patients J Urol 189 2013 2335
11. L. Nonn, V. Ananthanarayanan, P.H. Gann Evidence for field cancerization of the prostate Prostate 69 2009 1470
12. L. Richiardi, V. Fiano, L. Vizzini Promoter methylation in APC, RUNX3, and GSTP1 and mortality in prostate cancer patients J Clin Oncol 27 2009 3161
13. R. Henrique, F.R. Ribeiro, D. Fonseca High promoter methylation levels of APC predict poor prognosis in sextant biopsies from prostate cancer patients Clin Cancer Res 13 2007 6122
14. H.G. Welch, E.S. Fisher, D.J. Gottlieb Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era J Natl Cancer Inst 99 2007 1395
15. A.J. Vickers, M.J. Roobol, H. Lilja Screening for prostate cancer: early detection or overdetection? Annu Rev Med 63 2012 161
16. I.J. Powell, C.H. Bock, J.J. Ruterbusch Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity J Urol 183 2010 1792
17. A. Jemal, E. Ward, M. Thun Declining death rates reflect progress against cancer PLoS ONE 5 2010 e9584
18. B.V. Yanke, E.W. Salzhauer, I. Colon Is race a positive predictor of cancer on repeat prostate biopsy? J Urol 176 2006 1114
19. B. Kwabi-Addo, S. Wang, W. Chung Identification of differentially methylated genes in normal prostate tissues from African American and Caucasian men Clin Cancer Res 16 2010 3539
20. K. Woodson, R. Hayes, L. Wideroff Hypermethylation of GSTP1, CD44, and E-cadherin genes in prostate cancer among US Blacks and Whites Prostate 55 2003 199
21. O.N. Kryvenko, M. Jankowski, D.A. Chitale Inflammation and preneoplastic lesions in benign prostate as risk factors for prostate cancer Mod Pathol 25 2012 1023
22. J.G. Herman, J.R. Graff, S. Myohanen Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands Proc Natl Acad Sci U S A 93 1996 9821
23. H. Enokida, H. Shiina, S. Urakami Ethnic group-related differences in CpG hypermethylation of the GSTP1 gene promoter among African-American, Caucasian and Asian patients with prostate cancer Int J Cancer 116 2005 174
24. W.A. Sakr, D.J. Grignon, J.D. Crissman High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20-69: an autopsy study of 249 cases In Vivo 8 1994 439
25. B. Djavan, P. Mazal, A. Zlotta Pathological features of prostate cancer detected on initial and repeat prostate biopsy: results of the prospective European Prostate Cancer Detection study Prostate 47 2001 111
26. B.J. Trock, M.J. Brotzman, L.A. Mangold Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high-risk cohort of men with negative initial prostate biopsies BJU Int 110 2012 56